Press releases
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
- Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
More ▼
Key statistics
On Friday, Bio Rad Laboratories Inc (BUWA:BER) closed at 261.30, 3.69% above its 52-week low of 252.00, set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 261.30 |
---|---|
High | 261.30 |
Low | 261.30 |
Bid | 261.80 |
Offer | 263.20 |
Previous close | 271.70 |
Average volume | 4.30 |
---|---|
Shares outstanding | 33.61m |
Free float | 25.07m |
P/E (TTM) | -- |
Market cap | 9.44bn USD |
EPS (TTM) | -21.49 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 07:08 BST.
More ▼